Unilever to weigh raising offer for Glaxo consumer unit
Hedge fund Elliott builds multibillion-pound stake in GlaxoSmithKline
Bayer Shares Gain as Another Activist Investor Piles In
Solved Question 1 [20 marks] Bluebell capital investors, an
Factbox-Activist investor Bluebell's offensive against European giants heats up
GSK Stock: Why I'm Picking Up This Undervalued Gem (NYSE:GSK)
UK drugmaker GSK under fresh pressure to sell consumer arm, GlaxoSmithKline
Why activist investor Bluebell Capital is targeting BlackRock over 'ESG hypocrisy
Punchy Bluebell an unlikely ally to US giant in Glaxo stand-off